Compare Ishares Msci Italy ETF (EWI) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Italy ETF vs TransMedics Group Inc — how do they compare? Ishares Msci Italy ETF trades at $56.32 (market cap $1.14B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 2.4× Ishares Msci Italy ETF's market cap, and Ishares Msci Italy ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Italy ETF for 53 Days and TransMedics Group Inc for 24 Days on average.
| EWI | TMDX | |
|---|---|---|
Market Cap | $1.14B | $2.74B |
Volume | 2,377,947 | 949,331 |
Sector | Broad Market / Factor | Health |
52-Week High | $63.35 | $150.42 |
52-Week Low | $50.31 | $61.99 |
Typical Hold Time | 53 Days | 24 Days |
Enterprise Value | — | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWI (iShares MSCI Italy ETF) trades at $56.32, down slightly by 0.05% with a bearish technical signal from moving averages and oscillators. The ETF provides concentrated exposure to Italian financials, utilities, and industrials, benefiting from sector consolidation and EU recovery investments. Recent news highlights European Central Bank rate hikes and energy price pressures affecting eurozone markets.
The outlook remains cautious due to technical bearish signals and macroeconomic headwinds from ECB tightening. Investment opportunity lies in Italy's banking consolidation and infrastructure spending, but risks include eurozone economic sentiment deterioration and persistent inflation concerns.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ishares Msci Italy ETF
EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.
Read more on EWI →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
